(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ADK

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ADK

ST13

US500000079170253

Classe

9, 35, 42

Pedido

79170253

Registro

5010060

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

46

Atualização mais recente

09/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 35, 42

Data de depósito

22/05/2015

Data de registro

02/08/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/08/2023

Última transação

09/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Mechelen, BE

Examinador

FRENCH, CURTIS W

Unidade examinadora

M60

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

BIOCARTIS NV
BIOCARTIS NV

Representantes

Clifford D. Hyra FRESH IP PLC

Classificação técnica

Classes Nice

Classe 9Classe 35Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Computer software for the development of computer code for running assays and for processing of data related to assays in the fields of clinical and/or industrial diagnosis; computer software for medical research and data analysis; scientific and diagnostic apparatus and instrumentscomputer software to assist in the developmentrunning and analysis of assaysnot for medical purposescomputer software for analysingdisplaying and visualizing experimental databiological data and data from amplified analytes related to assays; computer software for the analysis of data processed from scientific apparatusinstruments and diagnostic apparatusmolecular diagnostic system comprised of an electronic computercartridges and mechanical manipulation machine to operate the cartridge for the detection and quantification of nucleic acidsproteinsinfectious agents and/or pathogens; computer software for remote handling of a scientific apparatusinstruments and diagnostic apparatusmolecular diagnostic system comprised of an electronic computercartridges and mechanical manipulation machine to operate the cartridge for the detection and quantification of nucleic acidsproteinsinfectious agents and/or pathogens in the field of diagnosticsclinical and/or industrial applications; all these aforementioned goods alone or in combination in use in the analysis and/or study phases of sampling or for use in the field of diagnostics

Classe 35

Compiling of information into computer databases and computerized word processing of data in the field of diagnosticsclinical and/or industrial applications; systemization of information in the nature of data and technical documentation into computer databases; updating and maintenance of information in the nature of data and technical documentation into computer databases; all these aforementioned services for use in the field of diagnosticsclinical and/or industrial applications

Classe 42

Scientific research for medical purposesscientific and technical analysisin the fields of life sciencesdiagnostics and medicine; chemical and biological analysis; chemistry servicesDNARNA and molecular analysis and screening services for scientific research and medical purposes; consultancy and advice relating to scientific research and development; design and development of medical diagnostic assay; developmentdesigninstallationmaintenance and updating of computer software in the field of diagnosticsclinical and/or industrial applications; installationmaintenanceupdating of computer software for a molecular diagnostic system for detection and quantification of nucleic acidsproteinsinfectious agents and/or pathogens

Publicações

Histórico de despachos e eventos da marca no USPTO.

46 publicações encontradas

ES71

TEAS SECTION 71 RECEIVED

09/07/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/08/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

22/05/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

02/06/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/05/2024

INPC

INVALIDATION PROCESSED

02/05/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

23/04/2024

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

27/02/2024

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

01/01/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

23/08/2023

71AG

REGISTERED-SEC.71 ACCEPTED

23/08/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

23/08/2023

ES71

TEAS SECTION 71 RECEIVED

01/02/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/08/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

16/07/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

31/10/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/01/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/12/2016

FIMP

FINAL DISPOSITION PROCESSED

29/12/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/11/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/09/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

02/08/2016

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/07/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/05/2016

PUBO

PUBLISHED FOR OPPOSITION

17/05/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/04/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

27/04/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/04/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

13/04/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/04/2016

DOCK

ASSIGNED TO EXAMINER

24/03/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/02/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/02/2016

ALIE

ASSIGNED TO LIE

22/02/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/02/2016

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

11/02/2016

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

21/01/2016

RFNT

REFUSAL PROCESSED BY IB

25/09/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/09/2015

RFRR

REFUSAL PROCESSED BY MPU

04/09/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/09/2015

CNRT

NON-FINAL ACTION WRITTEN

03/09/2015

DOCK

ASSIGNED TO EXAMINER

03/09/2015

MAFR

APPLICATION FILING RECEIPT MAILED

12/08/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/08/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/08/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ADK ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.